Reuters logo
BRIEF-Bayer announces FDA acceptance of supplemental biologics license application for Mybetaapp and Betaconnect navigator
December 14, 2016 / 5:21 PM / 10 months ago

BRIEF-Bayer announces FDA acceptance of supplemental biologics license application for Mybetaapp and Betaconnect navigator

Dec 14 (Reuters) - Bayer:

* Bayer announces fda acceptance of supplemental biologics license application for mybetaapp and betaconnect navigator Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below